Robert H Scannevin Selected Research

Robert H Scannevin Research Topics

Disease

10	Multiple Sclerosis 01/2017 - 03/2011
6	Parkinson Disease (Parkinson's Disease) 04/2022 - 02/2012
6	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 10/2011
5	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 04/2012
4	Synucleinopathies 04/2022 - 10/2016
3	Neuroinflammatory Diseases 10/2016 - 03/2011
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2015 - 03/2011
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2015
2	Ischemic Stroke 12/2008 - 01/2008
2	Stroke (Strokes) 12/2008 - 04/2007
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Huntington Disease (Huntington's Disease) 01/2018
1	Proteostasis Deficiencies 01/2018
1	Fibrosis (Cirrhosis) 10/2017
1	Neoplasms (Cancer) 10/2017
1	Gliosis 10/2016
1	Relapsing-Remitting Multiple Sclerosis 08/2015
1	Flushing 10/2013
1	Catalepsy 02/2012
1	Inflammation (Inflammations) 03/2011
1	Disease Progression 03/2011
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2008
1	Ischemia 12/2008
1	Infarction (Infarctions) 12/2008
1	Cerebral Hemorrhage 12/2008
1	Brain Ischemia (Cerebral Ischemia) 01/2008

Drug/Important Bio-Agent (IBA)

11	Dimethyl FumarateIBA 01/2021 - 03/2011
4	SynucleinsIBA 04/2022 - 10/2016
3	LipidsIBA 04/2022 - 12/2018
3	Transcription Factors (Transcription Factor)IBA 10/2016 - 03/2011
3	FumaratesIBA 04/2016 - 03/2011
3	Neuroprotective AgentsIBA 08/2015 - 03/2011
2	Carrier Proteins (Binding Protein)IBA 04/2022 - 12/2018
2	Stearoyl-CoA DesaturaseIBA 04/2022 - 01/2022
2	Biological ProductsIBA 01/2021 - 01/2008
2	ethyl fumarateIBA 01/2021 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2016
2	aducanumabIBA 01/2017 - 01/2016
2	Pharmaceutical PreparationsIBA 10/2016 - 02/2012
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 04/2016 - 10/2011
2	Amyloid (Amyloid Fibrils)IBA 04/2016 - 01/2016
2	monomethyl fumarateIBA 08/2015 - 10/2013
2	AntioxidantsIBA 04/2012 - 03/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2018
1	Matrix Metalloproteinases (MMPs)IBA 10/2017
1	Therapeutic UsesIBA 01/2017
1	BIIB042IBA 04/2016
1	Peptides (Polypeptides)IBA 04/2016
1	Protein Isoforms (Isoforms)IBA 04/2016
1	SaltsIBA 01/2015
1	Interferon-betaIBA 07/2014
1	Amyloid beta-PeptidesIBA 04/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2013
1	ProstaglandinsIBA 10/2013
1	Prostaglandin D2IBA 10/2013
1	Oxidopamine (6 Hydroxydopamine)IBA 02/2012
1	Reserpine (Serpasil)FDA Link 02/2012
1	Adenosine (Adenocard)FDA LinkGeneric 02/2012
1	Haloperidol (Haldol)FDA LinkGeneric 02/2012
1	AcidsIBA 10/2011
1	Myelin-Oligodendrocyte GlycoproteinIBA 03/2011
1	Free RadicalsIBA 03/2011
1	Minocycline (Cyclops)FDA LinkGeneric 12/2008
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2008
1	Matrix Metalloproteinase InhibitorsIBA 01/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2007

Therapy/Procedure

10	Therapeutics 04/2022 - 04/2007
1	Oral Administration 02/2012